Timeliness of Malaria Treatment in Children Under Five Years of Age in Sub-Saharan Africa: A Multicountry Analysis of National Household Survey Data
SR-15-119.pdf — PDF document, 4101 kB (4199705 bytes)
Author(s): Shah JA, Emina JBO, Ye Y
Malaria is one of the most severe public health problems worldwide, particularly for children under five years of age. The World Health Organization recommends prompt diagnosis and treatment with effective antimalarial medicines within 24 hours of the onset of fever. Delays in treatment can have fatal consequences, particularly if the infection is severe, but few studies systematically assess these delays among children under five years of age in Sub-Saharan Africa (SSA). This study examined the extent to which children under five years of age across SSA received an antimalarial treatment within 24 hours of the reported onset of fever. The study also investigated children under five years of age who received a first-line artemisinin combination therapy (ACT) within 24 hours of the reported onset of fever. Finally, the study identified predictors of prompt treatment with ACT and describes profiles of children who received this recommended treatment. The study focuses on the following countries prioritized by the United States’ President’s Malaria Initiative (PMI): Angola, Benin, Ethiopia, Ghana, Kenya, Liberia, Madagascar, Malawi, Mali, Mozambique, Rwanda, Senegal, Tanzania mainland, Uganda, Zambia, and Zanzibar.
This document is not available in print from MEASURE Evaluation.